ad image

Patent

1 / 1
Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains
Patented Production Strains

Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains

Trond Erik Vee Aune, Ph.D.

Vectron Biosolutions

PAO-08-022-CL-03Aug 16, 2022
Hovione Technology
Patent

Patent on Improved Particle Size Testing Method Granted to Hovione will Impact Market

Hovione Technology

PR-M11-20-039Feb 03, 2021
AbbVie
Legal

AbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim

AbbVie

PR-M05-19-NI-056May 20, 2019
Eli Lilly and Company
Legal

U.S. Court of Appeals Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit

Eli Lilly and Company

PR-M04-19-NI-089Apr 30, 2019
Perrigo Confirms Patent Challenge for Generic Version of Nascobal®
ANDA

Perrigo Confirms Patent Challenge for Generic Version of Nascobal®

Nice Insight

PR-M03-19-NI-020Mar 07, 2019
Sanofi
Patent

Regeneron and Sanofi Strongly Disagree with Verdict Upholding Three of Five Amgen U.S. Patent Claims Relating to PCSK9 Antibodies

Sanofi

PR-M02-19-NI-059Feb 26, 2019
Cellect Biotechnology Ltd.
Stem Cells

Cellect Receives Multiple Patent Grants

Cellect Biotechnology Ltd.

PR-M11-18-NI-021Nov 07, 2018
Perrigo
Patent

Perrigo Confirms Patent Challenge For Generic Version Of Kerydin®

Perrigo

PR-M11-18-NI-008Nov 02, 2018
Zynex
Patent

Zynex Obtains U.S. Patent for Blood Volume Monitor

Zynex

PR-M10-18-NI-044Oct 12, 2018
Amorsa Therapeutics
Drug Development

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

Amorsa Therapeutics

PR-M01-18-NI-029Jan 11, 2018
Vendanta Biosciences
Regulatory

Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics

Vendanta Biosciences

PR-M12-17-NI-009Dec 14, 2017
European Medical and Pharma Patent Filings Fell in 2016

European Medical and Pharma Patent Filings Fell in 2016

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M03-17-NI-010Mar 16, 2017
1 / 1